Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia

Clinical Microbiology and Infection

Volumn 8, Issue 2, 2002, Pages 93-100

  Brunkhorst, F M ^a   Al Nawas, B ^b   Krummenauer, F ^b   Forycki, Z F ^a   Shah, P M ^c  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

APACHE II; C reactive protein; Pneumonia; Procalcitonin; Sepsis; SIRS

Indexed keywords

C REACTIVE PROTEIN; PEPTIDE; PROCALCITONIN;

ARTICLE; BODY TEMPERATURE; CLINICAL OBSERVATION; CONTROLLED STUDY; DEATH; DIAGNOSTIC VALUE; DISEASE SEVERITY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SEPSIS; STATISTICAL SIGNIFICANCE;

EID: 0036462857     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2002.00349.x     Document Type: Article

References (31)

1. The prevalence of nosocomial infection in intensive care units in Europe
2. Nosocomial infection and fatality in medical and surgical intensive care unit patients
3. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia
4. Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies
5. Ventilator-associated pneumonia - Understanding epidemiology and pathogenesis to guide prevention and empiric therapy
6. Bacteriemia and severe sepsis in adults: A multicenter prospective survey in ICUs and wards of 24 hospitals
7. New approaches in the diagnosis of nosocomial pneumonia
8. Discrimination of infectious and non-infectious causes of early ARDS by Procalcitonin
9. The spectrum of patients strongly influences the usefulness of diagnostic tests for pneumonia
10. Procalcitonin in the diagnosis of severe infections
11. High serum procalcitonin concentrations in patients with sepsis and infection
12. Procalcitonin in patients with and without immunosuppression and sepsis
13. Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: Comparison with interleukin-8
14. Procalcitonin increase after endotoxin injection in normal subjects
15. Procalcitonin is higher in non-survivors at day one of the diagnosis of sepsis and severe sepsis/septic shock. I. International Jena Symposium
16. The natural history of the systemic inflammatory response syndrome (SIRS)
17. APACHE II. A severity of disease classification system
18. CDC definitions for nosocomial infections
19. Survival analysis using the SAS system: A practical guide
20. The value of white blood cell count and differential count in patients admitted to the ICU with and without infections
21. Serum calcitonin precursors in sepsis and systemic inflammation
22. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection
23. C-reactive protein as an indicator of resolution of sepsis in the intensive care unit
24. Procalcitonin, a new diagnostic and prognostic marker for severe infections
25. Procalcitonin and C-reactive protein levels in community-acquired pneumonia: Correlation with etiology and prognosis
26. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis
27. Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: Identification of subjects at high risk of mortality
28. Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome
29. Procalcitonin and C-reactive protein levels in neonatal infections
30. C-reactive protein and its cytokine mediators in intensive-care patients